Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-07 5:20 pm Purchase | 2024-11-18 | 13G | Inflection Point Acquisition Corp. II IPXX | Newtyn Management LLC | 700,000 8.300% | 700,000 (New Position) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | City Office REIT, Inc. CIO | Newtyn Management LLC | 3,938,000 9.800% | 734,758 (+22.94%) | Filing History |
| 2024-11-14 4:05 pm Unchanged | 2024-09-30 | 13G | Tectonic Therapeutic Inc TECX | Newtyn Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Franklin Street Properties Corp. FSP | Newtyn Management LLC | 7,150,000 6.900% | 7,150,000 (New Position) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | BV Financial, Inc. BVFL | Newtyn Management LLC | 682,980 5.800% | -317,020 (-31.70%) | Filing History |
| 2024-08-16 4:05 pm Purchase | 2024-08-07 | 13G | Theravance Biopharma, Inc. TBPH | Newtyn Management LLC | 4,100,000 8.400% | 4,100,000 (New Position) | Filing History |
| 2024-03-08 4:05 pm Purchase | 2024-02-28 | 13G | Veradigm Inc. MDRX | Newtyn Management LLC | 10,500,000 9.600% | 10,500,000 (New Position) | Filing History |
| 2024-03-07 6:00 pm Sale | 2024-03-05 | 13D | Sensei Biotherapeutics, Inc. SNSE | Newtyn Management LLC | 1,242,245 4.950% | -214,428 (-14.72%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | AVROBIO, Inc. AVRO | Newtyn Management LLC | 227,848 6.100% | 227,848 (New Position) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT | Newtyn Management LLC | 3,021,500 8.400% | 3,021,500 (New Position) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | City Office REIT, Inc. CIO | Newtyn Management LLC | 3,203,242 8.000% | 3,203,242 (New Position) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | BV Financial, Inc. BVFL | Newtyn Management LLC | 1,000,000 8.800% | 1,000,000 (New Position) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | PACIFIC GAS & ELEC CO 6 PR PCGPRA | Newtyn Management LLC | 0 0.000% | -665,610 (Position Closed) | Filing History |
| 2024-02-13 5:34 pm Sale | 2024-02-09 | 13D | Sensei Biotherapeutics, Inc. SNSE | Newtyn Management LLC | 1,456,673 5.830% | -277,485 (-16.00%) | Filing History |
| 2024-01-25 4:05 pm Purchase | 2023-01-17 | 13D | Merrimack Pharmaceuticals, Inc. MACK | Newtyn Management LLC | 1,873,694 13.100% | 354,587 (+23.34%) | Filing History |
| 2023-11-03 5:03 pm Purchase | 2023-10-25 | 13D | Sensei Biotherapeutics, Inc. SNSE | Newtyn Management LLC | 1,734,158 6.500% | 1,734,158 (New Position) | Filing History |
| 2023-05-23 4:05 pm Sale | 2023-05-19 | 13G | PACIFIC GAS & ELEC CO 6 PR PCGPRA | Newtyn Management LLC | 665,610 6.500% | -583,164 (-46.70%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | PFSweb, Inc. PFSW | Newtyn Management LLC | 1,206,502 5.300% | 1,206,502 (New Position) | Filing History |
| 2023-02-14 4:05 pm Sale | 2022-12-31 | 13G | PACIFIC GAS & ELEC CO 6 PR PCGPRA | Newtyn Management LLC | 1,248,774 12.100% | -38,767 (-3.01%) | Filing History |
| 2022-03-04 6:02 pm Purchase | 2022-02-10 | 13G | PACIFIC GAS & ELEC CO 6 PR PCGPRA | Newtyn Management LLC | 1,287,541 12.500% | 529,608 (+69.88%) | Filing History |